Immune dysfunction resulting from allogeneic haematopoietic stem cell transplantation
(aHSCT) predisposes one to an elevated risk of cytomegalovirus (CMV) infection. Changes …

A plasma metabolomic model obtained by means of untargeted 1H nuclear magnetic
resonance, to which taurine, choline, methylamine, total glutathione, trimethylamine N-oxide …

Metabolomics analysis of biofluids is increasingly being recognized as a useful tool for the
diagnosis and management of a number of infectious diseases. Here we showed that …

Chronic graft-versus-host disease (cGVHD) remains a significant late effect issue for
allogeneic hematopoietic cell transplantation (allo-HCT) survivors, contributing to morbidity …

Cytomegalovirus (CMV) is the most common viral infection in hematopoietic cell
transplantation (HCT) recipients. We performed deep phenotyping of CMV-specific T cells to …

Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is used in the treatment of
high-risk acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS); however …

The clinical outcome of allogeneic hematopoietic stem cell transplantation (SCT) may be
influenced by the metabolic status of the recipient following conditioning, which in turn may …

Cytomegalovirus (CMV) DNAemia occurs frequently in CMV-seropositive allogeneic
hematopoietic stem cell transplant (allo-HSCT) recipients, and usually results from …

Allogeneic hematopoietic cell transplantation (allo-HCT) remains the sole curative option for
many hematological malignancies and other diseases. Nevertheless, its application is …

Allogeneic stem cell transplantation is used in the treatment of younger patients with severe
hematological diseases, especially hematological malignancies, and acute graft versus host …